Bernard Fox: Weekend at Bernie’s or 47 hours of TIMO2025
Bernard Fox, Co-Founder, President, and CEO of UbiVac, shared an article on LinkedIn:
“It’s a WRAP – “Weekend at Bernie’s” or “47 hrs of TIMO2025”.
47 hrs of GREAT science and best discussion in ages!
Sumit Subudhi, Douglas McNeel, Sergio Quezada, Michael Bachmann, Marion Subklewe, Michele Maio, Ofer Mandelboim, Cerwenka Adelheid, Lorenzo Moretta and many more – All hosted by Prof Barbara Seliger.
I discussed our work on Dark Genome-derived Dark Matter (Dark Proteome) & highlighted recent work from William Freed-Pastor published in SCIENCE 5/8/25 and work from Perreault Claude published in NATURE 5/22/25.
These studies are fundamentally changing cancer treatment, providing insights into why combination immunotherapy with personalized neoantigen vaccines are SUBOPTIMAL.
This is SPECTACULAR WORK from 2 large groups!!”
Bernard Fox reflected on key discussions from TIMO2025, a major scientific event featuring global immunotherapy experts. He presented UbiVac’s research on the Dark Proteome and emphasized new studies that are reshaping understanding of combination immunotherapy.
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer.
Authors: Anca Apavaloaei, Qingchuan Zhao, Leslie Hesnard, Maxime Cahuzac, Chantal Durette, Jean-David Larouche, Marie-Pierre Hardy, Krystel Vincent, Sylvie Brochu, Jean-Philippe Laverdure, Joël Lanoix, Mathieu Courcelles, Patrick Gendron, Mathieu Lajoie, Maria Virginia Ruiz Cuevas, Eralda Kina, Julie Perrault, Juliette Humeau, Grégory Ehx, Sébastien Lemieux, Ian R. Watson, Daniel E. Speiser, Michal Bassani-Sternberg, Pierre Thibault, and Claude Perreault.
You can read the full article on Journal of Nature Cancer.
More posts featuring Bernard Fox.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023